BioPharma Dive September 8, 2025
Sponsored content By IQVIA Technologies
Modern obesity trials are inherently complex, but the momentum behind these therapeutics has never been greater. With over $30 billion invested globally in 2024, the pace of innovation is accelerating. Yet for many sponsors, scientific ambition still outpaces the realities of trial execution.
Often spanning multiple endpoints, comorbidities and behavior outcomes, obesity trials require more than just a sound protocol. They demand speed, agility and a deeper understanding of the patient experience. The sponsors leading the space aren’t just focused on trial execution; they’re reframing trial design by prioritizing strategies that connect science and technology to deliver fit-for-purpose solutions that accurately capture the patient experience.
Digital technology and strategy must work together
Digital tools...
Today's Sponsors
Today's Sponsor